Literature DB >> 31911200

A novel in silico platform for a fully automatic personalized brain tumor growth.

Mojtaba Hajishamsaei1, Ahmadreza Pishevar1, Omid Bavi2, Madjid Soltani3.   

Abstract

Glioblastoma Multiforme is the most common and most aggressive type of brain tumors. Although accurate prediction of Glioblastoma borders and shape is absolutely essential for neurosurgeons, there are not many in silico platforms that can make such predictions. In the current study, an automatic patient-specific simulation of Glioblastoma growth would be described. A finite element approach is used to analyze the magnetic resonance images from patients in the early stages of their tumors. For segmentation of the tumor, the Support Vector Machine (SVM) method, which is an automatic segmentation algorithm, is used. Using in situ and in vivo data, the main parameters of tumor prediction and growth are estimated with high precision in proliferation-invasion partial differential equation, using the genetic algorithm optimization method. The results show that for a C57BL mouse, the differences between the area and perimeter of in vivo test and simulation prediction data, as the objective function, are 3.7% and 17.4%, respectively.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain tumor; Genetic algorithm; Glioblastoma; Personalized tumor growth; Support vector machine

Year:  2020        PMID: 31911200     DOI: 10.1016/j.mri.2019.12.012

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  2 in total

1.  Tracing the footsteps of autophagy in computational biology.

Authors:  Dipanka Tanu Sarmah; Nandadulal Bairagi; Samrat Chatterjee
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

2.  SARS-CoV-2 rate of spread in and across tissue, groundwater and soil: A meshless algorithm for the fractional diffusion equation.

Authors:  O Bavi; M Hosseininia; M H Heydari; N Bavi
Journal:  Eng Anal Bound Elem       Date:  2022-02-09       Impact factor: 2.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.